The Company has a Long-Term Incentive Plan, or LTIP. The LTIP was approved by the Company’s shareholders to provide the incentive of long-term stock-based awards to officers, directors, and key employees. The LTIP provides for the granting of nonqualified stock options, incentive stock options, stock appreciation rights, performance restricted stock grants and units, restricted stock grants and units, and unrestricted stock grants. The maximum number of shares of common stock subject to awards that may be granted to any participant in any one calendar year is 10,000. Shares of common stock issued under the LTIP may be treasury shares or authorized but unissued shares. The LTIP will be administered by the Compensation and Human Capital Committee of the Board, or the full Board, provided that the full Board will administer the LTIP as it relates to awards to non-employee directors of the Company. The LTIP was originally effective on July 1, 2016 (“2016 LTIP”), and was amended, restated, and renamed the 2025 LTIP effective on May 6, 2025 (“2025 LTIP”). The Company filed a registration statement with the Securities and Exchange Commission on May 6, 2025 covering the offering of stock under the 2025 LTIP. The registration statement added 150,000 shares to the 55,786 unissued shares from the 2016 LTIP, which may be issued under the 2025 LTIP over ten years.

On May 4, 2026, the Board awarded stock to non-employee directors effective May 4, 2026. This stock award vested immediately. On May 4, 2026, the Compensation and Human Capital Committee awarded restricted stock to officers and key employees effective May 4, 2026. The stock award vests ratably over three years beginning May 4, 2026.

The restricted stock awards provide the grantee with the rights of a shareholder, including the right to receive dividends, subject to vesting restrictions, and to vote such shares, but not the right to sell or otherwise transfer the shares during the restriction period. As a result, the awards are included in common shares outstanding on the balance sheet. Restricted stock awards result in compensation expense valued at the fair market value of the stock on the date of the grant and are amortized ratably over the requisite service period.

For the three months ended June 30, 2026 and 2025, the statement of income includes $75 and $98 of stock-based compensation, respectively, and related recognized tax benefits of $20 and $26, respectively. For the six months ended June 30, 2026 and 2025, the statement of income includes $116 and $170 of stock-based compensation, respectively, and related recognized tax benefits of $31 and $46, respectively. Total stock-based compensation related to nonvested awards not yet recognized is $343 at June 30, 2026, which will be recognized over the remaining three-year vesting period.